CN102078510B - Chinese medicinal composition for treating coronary heart disease - Google Patents

Chinese medicinal composition for treating coronary heart disease Download PDF

Info

Publication number
CN102078510B
CN102078510B CN2011100261281A CN201110026128A CN102078510B CN 102078510 B CN102078510 B CN 102078510B CN 2011100261281 A CN2011100261281 A CN 2011100261281A CN 201110026128 A CN201110026128 A CN 201110026128A CN 102078510 B CN102078510 B CN 102078510B
Authority
CN
China
Prior art keywords
parts
radix
coronary heart
chinese medicinal
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011100261281A
Other languages
Chinese (zh)
Other versions
CN102078510A (en
Inventor
孙华清
徐韬
王领台
赵厚珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011100261281A priority Critical patent/CN102078510B/en
Publication of CN102078510A publication Critical patent/CN102078510A/en
Application granted granted Critical
Publication of CN102078510B publication Critical patent/CN102078510B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicinal composition for treating coronary heart disease. The Chinese medicinal composition is a preparation prepared from the following raw materials: cauterized astragalus, codonopsis pilosula, cauterized liquoric root, snakegourd fruit, longstamen onion bulb, safflower, szechuan lovage rhizome, trogopterus dung, root of red-rooted salvia heated with liquor, suberect spatholobus stem, motherwort herb, processed rhizoma pinelliae, tangerine peel, cassia twig, oriental waterplantain rhizome, atraotydin, bitter orange and dwarf lilyturf tuber. The formula is suitable for vitality deficiency and phlegm stasis congesting type coronary heart diseases which are common clinically. Clinical verification of clinical 1,486 patients shows that the Chinese medicinal composition has quick response, exact curative effects, high efficiency, a small number of complications and good long-term effects, is economical and practical, is easily accepted by patients and has certain scientificity, advancement and practicability. The raw materials of the Chinese medicinal composition have wide sources, high quality and low price, so that the Chinese medicinal composition is worthy of popularizing in basic levels.

Description

The Chinese medicine composition of treatment coronary heart disease
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of coronary heart disease, specifically is the oral formulations of feedstock production with the Chinese herbal medicine.
Background technology
Coronary heart disease is common clinically frequently-occurring disease, commonly encountered diseases, the retrosternal pain that its characteristics of lesion is shown effect repeatedly, can involve pareordia, pain is press for extracting juice property or vexed bloated property, asphyxiating pain, and take on left, the inboard radiation of left upper extremity, the fatigue of being everlasting, excited, catch cold, bring out under the factor affecting such as smoking, mainly be because of coronary insufficiency, cause myocardial ischemia, temporary ischemia, the clinical symptoms that anoxia causes, the traditional Chinese medical science thinks that primary disease belongs to " angina pectoris ", " precordial pain with cold limbs ", " thoracic obstruction " category, outbreak to primary disease on Huang di's Canon of Medicine just has detailed description, as: " opinion piece of writing when element is asked and hidden the Cuttings method " has: " heart patient chest pain, discomfort and fullness in the hypochondrium; pain over the hypochondrium; bear pain between back of the body shoulder, pain in the medial sides of both arms ", its pain are, very then " chest pain radiating to the back, backache radiating to the heart " or " the pain as being stabbed heart ".
Motherland's medical science thinks that primary disease mainly shows as deficiency in origin and excess in superficiality, simulataneous insufficiency and excessive, and it is empty that its deficiency in origin can have yang blood and qi to lose, and mark is real to be the stagnation of QI, cold coagulation, turbid, the blood stasis of expectorant, and again can be sick each other mutually, its pathogenesis is a blockage of the cardiac vessels, and its sick position is based on the heart, and relevant with liver,spleen,kidney three dirty functional disorders.
Modern medicine is thought, coronary heart disease is because coronary atherosclerosis, or thrombosis is attached to causing coronary stricture on the coronary blood tube wall, reduce by coronary artery blood flow, when the heart load increases suddenly, need blood volume to increase, the compensatory capacity that has surpassed the coronary artery blood supply, or need blood volume not increase, but coronary spasm, reduced blood flow, or above-mentioned factor exists simultaneously, can cause that all heart is rapid, temporary transient ischemia, anoxia and angina pectoris takes place, the direct factor that produces pain perception may be because during myocardial ischemia-anoxemia, too much metabolite such as lactic acid, acidic materials and polypeptides matters such as acetone acid, the centripetal fiber tip of autonomic nerve in the cardiac stimulus, reach brain through the corresponding spinal cord section of 1-5 breast sympathetic ganglion and produce the pain sensation and various discomfort, this sense of discomfort has also can involve gastrointestinal tract, cervical region, tooth and back etc.
At present, the method of treatment coronary heart disease is varied both at home and abroad, the treatment means one main as doctor trained in Western medicine is coronary artery dilator, the 2nd, the formation of anti-tampon and the gathering of thrombosis, cause the narrow of tube chamber, the minimizing of blood flow, but most of curative effect instability, the course of disease is long, outbreak repeatedly, effect is undesirable, expands art though many in recent years hospitals can carry out coronary artery, and price is expensive, and certain risk is arranged, most of patients can not be accepted, and be subjected to the restriction of age and armarium again, can not extensively popularize.
Summary of the invention
The objective of the invention is provides a kind of Chinese medicine composition for the treatment of coronary heart disease for overcoming above-mentioned the deficiencies in the prior art, and this Chinese medicine composition is to the coronary heart disease special effect, and curative effect is fast, short treating period, and stable curative effect is difficult for recurrence.
For achieving the above object, the present invention adopts following technical proposals:
A kind of Chinese medicine composition for the treatment of coronary heart disease, it is the medicament of being made by the raw material of following weight parts: 30~40 parts of Radix Astragali Preparatas, 10~15 parts of Radix Codonopsis, 9~12 parts of Radix Glycyrrhizae Preparatas, 20~30 parts of Fructus Trichosanthis, 20~30 parts of Bulbus Allii Macrostemonis, 5~10 parts on Flos Carthami, 10~15 parts of Rhizoma Chuanxiongs, 10~15 parts of Oletum Trogopteroris, wine are fried 20~30 parts of Radix Salviae Miltiorrhizaes, 20~30 parts of Caulis Spatholobis, 20~30 parts of Herba Leonuris, 10~15 parts of Rhizoma Pinelliae Preparata, 9~12 parts of Pericarpium Citri Reticulataes, 5~10 parts of Ramulus Cinnamomi, 20~30 parts of Rhizoma Alismatis, 10~15 parts of Rhizoma Atractylodis, 9~12 parts of Fructus Aurantiis, 9~12 parts of Radix Ophiopogonis.
Wherein the weight portion of each raw material is: 40 parts of Radix Astragali Preparatas, 15 parts of Radix Codonopsis, 12 parts of Radix Glycyrrhizae Preparatas, 30 parts of Fructus Trichosanthis, 30 parts of Bulbus Allii Macrostemonis, 10 parts on Flos Carthami, 15 parts of Rhizoma Chuanxiongs, 15 parts of Oletum Trogopteroris, wine are fried 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Caulis Spatholobis, 30 parts of Herba Leonuris, 15 parts of Rhizoma Pinelliae Preparata, 12 parts of Pericarpium Citri Reticulataes, 10 parts of Ramulus Cinnamomi, 30 parts of Rhizoma Alismatis, 15 parts of Rhizoma Atractylodis, 12 parts of Fructus Aurantiis, 12 parts of Radix Ophiopogonis.
Described medicament is an oral formulations.
Comprise also on the pharmaceutics that acceptable carrier and/or adjuvant make.
The preparation method of the Chinese medicine composition of described treatment coronary heart disease is: get the umber oven dry of each component raw material, grind impalpable powder, cross 300 mesh sieves, make oral formulations according to a conventional method and get final product.Described oral formulations comprises capsule, tablet or oral liquid etc.
The pharmacological action of each crude drug and compatibility characteristics are summarized as follows:
Radix Astragali Preparata, Radix Codonopsis, Radix Glycyrrhizae Preparata: QI invigorating heart tonifying power, Xin Gan share, and yang-energy is living, brings into play to strengthen hemodynamic, qi being the governor of blood, the capable then blood of gas is capable.
Fructus Trichosanthis, Bulbus Allii Macrostemonis: the circulation of qi promoting that activates yang, removing obstruction for relieving pain, lung heat clearing away, sputum eliminating.
Ramulus Cinnamomi, Radix Glycyrrhizae, Bulbus Allii Macrostemonis: logical heart-yang a surname numbness, the property of Ramulus Cinnamomi, the equal tool activating YANG with pungent and warm drugs of Bulbus Allii Macrostemonis wherein, the power of Ramulus Cinnamomi promoting the flow of QI in the collateral by warming the meridian is stronger, has the effect of diastole peripheral blood vessel, and the effect of Bulbus Allii Macrostemonis is promoting the circulation of QI to relieve pain.
Flos Carthami, Rhizoma Chuanxiong, Oletum Trogopterori, Radix Salviae Miltiorrhizae, Herba Leonuri, Caulis Spatholobi: blood circulation promoting and blood stasis dispelling, eliminating blood stasis to promote regeneration of blood, pain relieving, wherein, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Herba Leonuri have obvious coronary artery dilator effect, regional blood flow is increased, improve blood supply and oxygen supply, reach activating stagnated YANG, make by the damage focus and recover gradually.
Radix Salviae Miltiorrhizae, Ramulus Cinnamomi: warm promoting blood circulation.
Fructus Trichosanthis, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Fructus Aurantii: turbid, the regulating qi-flowing for activating stagnancy of eliminating phlegmization.
Rhizoma Atractylodis: fragrance, the spleen strengthening and damp drying is used for the vexed greasy fur person of gastral cavity of retention of dampness in middle-JIAO more.
Rhizoma Alismatis: promoting diuresis to eliminate damp pathogen, the drink that eliminates the phlegm, and effect for reducing fat is arranged, suppress blood cholesterol and alleviate atherosclerosis.
Radix Ophiopogonis: cardiotonic is arranged, and YIN nourishing liquid is in case medicine is crossed dry impairment of YIN.
The present invention is according to China's traditional medical theory, dialectical executing controlled, the prescription legislation, with benefiting QI for activating blood circulation, removing blood stasis reduces phlegm, the pain relieving that activates yang is main treatment approach, according to the theory of the traditional Chinese medical science " stagnation of QI and blood may bring about pain ", adopt differential diagnosis of diseases and the dialectical method that combines, found and mend, logical, row is held concurrently mutually and is dredged balance treatment, adopt the principle of " based on benefit; to lead to is usefulness ", " benefit " mainly is QI invigorating, and " leading to " mainly is that vital energy regualting and blood circulation-promoting reduces phlegm, OK, main row stagnates, and the invigorating middle warmer residence is logical, and mending not, harmony stagnates, not logical just the damage, the principle of capable not dispelling the stagnated QI, coronary heart disease is made clarify a diagnosis in, analyze in conjunction with the theory that the dialectical opinion of Chinese medicine is controlled, classification therapy research, be primarily aimed at the rather common clinically deficiency of vital energy, expectorant stasis of blood impatency type coronary heart disease is carried out diagnosis and treatment, and this kind of clinical manifestation mainly contains uncomfortable in chest, pained, cardiopalmus, breathe hard, the limb fiber crops, dizzy, greasy fur on tongue or tongue have petechia, ecchymosis, thready and hesitant pulse or short the knot generation.According to the observation this kind of clinical common be the type that a deficiency and excess is held concurrently mutually, be guiding principle with the disease, disease is closed ginseng, comprehensive with the integrity that enriches clinical diagnosis and treatment.In clinical treatment, the refined diagnosis technology that the macroscopical dialectical opinion of Chinese medicine is controlled with modern medicine applies in the clinical experimentation, according to the dialectical medication of the state of an illness.
The present invention has given prominence to the characteristic of treatment by Chinese herbs, and to the coronary heart disease special effect, curative effect is fast, short treating period, and stable curative effect is difficult for recurrence, and is economical and practical.10 days is a course of treatment, and 5-7 days take effect.
Promptly take an evident turn for the better 2-3 the course of treatment, and all diseases disappear, state of an illness control, and noinvasive is painless, and the pure natural traditional Chinese medical science is easy to use, without any side effects, this prescription is applicable to the rather common clinically deficiency of vital energy, expectorant stasis of blood resistance numbness type coronary heart disease, through clinical 1486 routine patients' clinical verification, instant effect, determined curative effect, effective percentage height (93.12%), complication is few, and long-term effect is good, and economical and practical, the patient is ready to receive treatment, again the certain science of tool, advance and practicality.Raw material sources of the present invention are extensive, super quality and competitive price, and cost is low, is worth promoting in basic unit.
Below in conjunction with clinical data and case beneficial effect of the present invention is described further.
One, data and method:
1. clinical data: be selected from December, 2003-2010 year December, the outpatient service of complete data and inpatient be totally 1486 examples, be divided into treatment at random and organize 786 examples, matched group 700 examples, the treatment group age is 46-78 year, course of disease 1-20, matched group age 45-77 year, course of disease 1.5-19, men and women's the course of disease when is through X 2 test (P>0.05), no difference of science of statistics.
2. Therapeutic Method: the treatment group is divided 3 times with the prepared prescription medicament of the embodiment of the invention 2 every day, oral meal, 10 days is a course of treatment, matched group oral administered compound Radix Salviae Miltiorrhizae one day 3 times, one time 3.
3. statistical method: two groups clinical uses X 2 test, and relatively, the RIDUT check is as shown in table 1 between two groups.
Table 1 liang group treatment synopsis
Figure GDA0000081353490000031
Annotate: P<0.01
4. side effect and contraindication:
1. side effect through the 1486 patients clinical observation of curative effect in 7 years, is not found obvious toxic-side effects.
2. contraindication: allergic constitution patient forbidding.
Example 1 man, 53 years old.
Year surplus the coronary disease medical history 10, in March, 2007, excuse was dizzy heavy, cardiopalmus, lose heart, uncomfortable in chest, Electrocardioscopy is a coronary insufficiency companion ocular fundus arteriosclerosis, 3 chest pains take place suddenly in May, 2007, the pain gesture is acute, contains FUFANG DANSHEN DIWAN and begins to such an extent that alleviation takes place frequently in January later on, and dizzy breast gastral cavity painful abdominal mass is vexed when sending out, breathe hard and seemingly breathe heavily, be diagnosed as coronary heart disease, almost outbreak every day recently, day is sent out 2,3 times at most, have a pain with uncomfortable in chest, suffocated breathing, gastral cavilty traction when sending out, the sore spot tenderness, the time desire belch, companion's cough, abundant expectoration, color are white.Inspection is seen: the purple gas of enlarged tongue, tongue are greasy in vain, Sublingual stasis of blood hypertrophy of tendon and muscle purple, pulse condition stringy and rolling pulse, a left side is puckery, lethargy is weary refreshing, and differential diagnosis in tcm is yang deficiency weakness of QI, insufficiency of pectoral QI, phlegm-turbidity and blood stasis resistance, blood vessels numbness resistance heart stomach, and stagnation of QI and blood may bring about pain is controlled with benefiting QI for activating blood circulation, and removing blood stasis reduces phlegm.Took capsule of the present invention 20 days, disease greatly takes a turn for the better, and continues to take a course of treatment, and state of an illness control is advised and continued to take medicine medical treatment, as a means of consolidation, follows up a case by regular visits to condition of illness half a year and does not recur.
Example 2 patients, man, 66 years old.
Existing 3 years of patient's precordialgia variable interval outbreak, cause feelings will was not relaxed and was caused the state of an illness and increase the weight of March, in certain examination in hospital electrocardio diagram: premature ventricular beat, after this ventricular premature contraction never is interrupted, I, II, the V4-V6 ST section of leading moves down 0.1mV companion T ripple and is inverted lipid examination, T-CHOL 7.8mmol/L, triglyceride 3.2mmol/L, be diagnosed as coronary heart disease, hyperlipemia does not obtain produce effects through the treatment of clothes FUFANG DANSHEN PIAN, existing pareordia twinge, labor is promptly done slightly, last 5-10 minute, repose or the buccal Radix Salviae Miltiorrhizae drop pill after alleviation is arranged slightly, the companion is nervous uncomfortable in chest, breathe hard, the whole body is sleepy, difficulty in walking, edema over the face and pale, body puffiness due to deficiency, indigestion and loss of appetite lack of appetite, abundant expectoration, color is white, checks and sees petechia is arranged purplish tongue, tongue is greasy in vain, stringy and thready pulse and puckery.The differential diagnosis in tcm phlegm-turbidity and blood stasis stagnates, and the resistance of blood vessels numbness is controlled with benefiting QI for activating blood circulation, the removing blood stasis that reduces phlegm, and takes this capsule after 10 days, ventricular premature contraction disappears, and continues to take 2 courses of treatment and have an electro-cardiogram, and it is normal that ST-T recovers, and the state of an illness is controlled, symptom takes a turn for the better, and takes care of oneself, advise patient to continue to take medicine three months after recurrence.
Example 3 men, 49 years old, the cadre.
, uncomfortable in chest nervous before 2 years because of the pareordia discomfort, examine at certain examination in hospital and to be coronary heart disease, the first quarter moon cause is busy with one's work, and operating pressure is big, the burst precordialgia, fixing do not move that the companion is uncomfortable in chest, cardiopalmus, malaise, through western medical treatment, medication is ominous, and symptom take a favorable turn slightly, before February again because of quarreling with the colleague at work, mood is not smooth, the burst precordialgia and is had a sense of urgency, and illustrates with dizzy, uncomfortable in chest, shortness of breath and fatigue, cardiopalmus, electrocardio: 1. sinus tachycardia; 2. I, V5, V6T ripple are inverted, patient's obesity, and happiness food rich and fatty diet lacks motion at ordinary times, and abundant expectoration is checked and is seen that the thin white matter of tongue is fat at ordinary times, and the end, reflected livid purple, a little less than heavy cun of the thready pulse, GUAN-pulse band string, this is the thoracic obstruction, qi deficiency and phlegm stagnation syndrome blood stasis, controls with benefiting QI for activating blood circulation, removing blood stasis reduces phlegm.After taking this capsule 15 days, state of an illness basic controlling was taken a course of treatment again, and ECG T wave is upright, did not follow up a case by regular visits to recurrence again after January, advised patient to continue medication, with solid curative effect.
Example 4 king XX, the woman, 47 years old, the primary sports teacher, on July 21st, 2005 went to a doctor.
Suffer from coronary heart disease, preceding pain uncomfortable in chest show effect repeatedly 4 years surplus, the clothes western medicines in treatment, the time end the commentaries on classics of not getting better when sending out.The unexpected left front breast severe pain of cause in January, to my institute's emergency treatment, examining is acute preceding partition myocardial infarction, remission after treating, but still sense pareordia painful abdominal mass plug uncomfortable in chest, the time do twinge, require to change treatment by Chinese herbs into, examine and see that the patient is except that last disease, with losing heart, the time cough and spit white thick expectorant, the companion is dizzy sleepy, cardiopalmus.Inspection is seen: light red tongue and dark, sublingual vein stasis of blood purple, tongue is greasy in vain, deep and tense pulse, the tcm diagnosis thoracic obstruction, for the turbid impatency of the QI and blood stasis of blood in the heart, when with " leading to " for curing mainly it, the removing blood stasis that reduces phlegm, promoting flow of QI and blood.
Change this capsule of clothes after three courses of treatment, greatly take a turn for the better, the state of an illness is controlled substantially, and it is normal that ECG ST section recovers, and the T ripple changes upright by being inverted, and advises patient to continue to take.With we is main plus-minus advance and retreat, and it is surplus to nurse one's health the moon again, and all diseases disappear, and advise and continue to take medicine medical treatment, as a means of consolidation.
The specific embodiment
The present invention is further described below in conjunction with embodiment.
Embodiment 1
Radix Astragali Preparata 30g, Radix Codonopsis 15g, Radix Glycyrrhizae Preparata 10g, Fructus Trichosanthis 30g, Bulbus Allii Macrostemonis 30g, Flos Carthami 10g, Rhizoma Chuanxiong 15g, Oletum Trogopterori 15g, Radix Salviae Miltiorrhizae (wine stir-fry) 20g, Caulis Spatholobi 20g, Herba Leonuri 30g, Rhizoma Pinelliae Preparata 12g, Pericarpium Citri Reticulatae 10g, Ramulus Cinnamomi 10g, Rhizoma Alismatis 20g, Rhizoma Atractylodis 15g, Fructus Aurantii 12g, Radix Ophiopogonis 12g, impalpable powder is ground in oven dry, cross 300 mesh sieves, the 1# capsule of packing into is promptly made the Chinese medicinal tablet of treatment coronary heart disease.
Embodiment 2
Radix Astragali Preparata 40g, Radix Codonopsis 15g, Radix Glycyrrhizae Preparata 12g, Fructus Trichosanthis 30g, Bulbus Allii Macrostemonis 30g, Flos Carthami 10g, Rhizoma Chuanxiong 15g, Oletum Trogopterori 15g, Radix Salviae Miltiorrhizae (wine stir-fry) 30g, Caulis Spatholobi 30g, Herba Leonuri 30g, Rhizoma Pinelliae Preparata 15g, Pericarpium Citri Reticulatae 12g, Ramulus Cinnamomi 10g, Rhizoma Alismatis 30g, Rhizoma Atractylodis 15g, Fructus Aurantii 12g, Radix Ophiopogonis 12g, impalpable powder is ground in oven dry, cross 300 mesh sieves, make tablet, promptly make the Chinese medicinal capsule of treatment coronary heart disease.
This example is the embodiment of preferred plan.
Embodiment 3
Radix Astragali Preparata 30g, Radix Codonopsis 12g, Radix Glycyrrhizae Preparata 10g, Fructus Trichosanthis 30g, Bulbus Allii Macrostemonis 20g, Flos Carthami 6g, Rhizoma Chuanxiong 15g, Oletum Trogopterori 10g, Radix Salviae Miltiorrhizae (wine stir-fry) 20g, Caulis Spatholobi 30g, Herba Leonuri 30g, Rhizoma Pinelliae Preparata 15g, Pericarpium Citri Reticulatae 12g, Ramulus Cinnamomi 6g, Rhizoma Alismatis 30g, Rhizoma Atractylodis 15g, Fructus Aurantii 12g, Radix Ophiopogonis 10g, impalpable powder is ground in oven dry, cross 300 mesh sieves, make oral liquid, promptly treat the oral liquid of coronary heart disease.
Embodiment 4
Radix Astragali Preparata 30g, Radix Codonopsis 12g, Radix Glycyrrhizae Preparata 10g, Fructus Trichosanthis 15g, Bulbus Allii Macrostemonis 20g, Flos Carthami 6g, Rhizoma Chuanxiong 15g, Oletum Trogopterori 10g, Radix Salviae Miltiorrhizae (wine stir-fry) 20g, Caulis Spatholobi 30g, Herba Leonuri 20g, Rhizoma Pinelliae Preparata 10g, Pericarpium Citri Reticulatae 10g, Ramulus Cinnamomi 6g, Rhizoma Alismatis 30g, Rhizoma Atractylodis 12g, Fructus Aurantii 12g, Radix Ophiopogonis 10g, impalpable powder is ground in oven dry, cross 300 mesh sieves, make oral liquid, promptly treat the oral liquid of coronary heart disease.
Embodiment 5
Radix Astragali Preparata 35g, Radix Codonopsis 12g, Radix Glycyrrhizae Preparata 9g, Fructus Trichosanthis 20g, Bulbus Allii Macrostemonis 25g, Flos Carthami 9g, Rhizoma Chuanxiong 10g, Oletum Trogopterori 12g, Radix Salviae Miltiorrhizae (wine stir-fry) 25g, Caulis Spatholobi 25g, Herba Leonuri 20g, Rhizoma Pinelliae Preparata 10g, Pericarpium Citri Reticulatae 9g, Ramulus Cinnamomi 5g, Rhizoma Alismatis 25g, Rhizoma Atractylodis 10g, Fructus Aurantii 9g, Radix Ophiopogonis 9g, impalpable powder is ground in oven dry, cross 300 mesh sieves, make tablet, promptly make the Chinese medicinal tablet of treatment coronary heart disease.
Embodiment 6
Radix Astragali Preparata 30g, Radix Codonopsis 10g, Radix Glycyrrhizae Preparata 9g, Fructus Trichosanthis 25g, Bulbus Allii Macrostemonis 20g, Flos Carthami 5g, Rhizoma Chuanxiong 12g, Oletum Trogopterori 10g, Radix Salviae Miltiorrhizae (wine stir-fry) 15g, Caulis Spatholobi 20g, Herba Leonuri 25g, Rhizoma Pinelliae Preparata 10g, Pericarpium Citri Reticulatae 9g, Ramulus Cinnamomi 5g, Rhizoma Alismatis 30g, Rhizoma Atractylodis 12g, Fructus Aurantii 10g, Radix Ophiopogonis 9g, impalpable powder is ground in oven dry, cross 300 mesh sieves, make oral liquid, promptly treat the oral liquid of coronary heart disease.

Claims (3)

1. a Chinese medicine composition for the treatment of coronary heart disease is characterized in that, it is the medicament of being made by the raw material of following weight parts; 30~40 parts of Radix Astragali Preparatas, 10~15 parts of Radix Codonopsis, 9~12 parts of Radix Glycyrrhizae Preparatas, 20~30 parts of Fructus Trichosanthis, 20~30 parts of Bulbus Allii Macrostemonis, 5~10 parts on Flos Carthami, 10~15 parts of Rhizoma Chuanxiongs, 10~15 parts of Oletum Trogopteroris, wine are fried 20~30 parts of Radix Salviae Miltiorrhizaes, 20~30 parts of Caulis Spatholobis, 20~30 parts of Herba Leonuris, 10~15 parts of Rhizoma Pinelliae Preparata, 9~12 parts of Pericarpium Citri Reticulataes, 5~10 parts of Ramulus Cinnamomi, 20~30 parts of Rhizoma Alismatis, 10~15 parts of Rhizoma Atractylodis, 9~12 parts of Fructus Aurantiis, 9~12 parts of Radix Ophiopogonis.
2. the Chinese medicine composition of treatment coronary heart disease according to claim 1, wherein the weight portion of each raw material is: 40 parts of Radix Astragali Preparatas, 15 parts of Radix Codonopsis, 12 parts of Radix Glycyrrhizae Preparatas, 30 parts of Fructus Trichosanthis, 30 parts of Bulbus Allii Macrostemonis, 10 parts on Flos Carthami, 15 parts of Rhizoma Chuanxiongs, 15 parts of Oletum Trogopteroris, wine are fried 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Caulis Spatholobis, 30 parts of Herba Leonuris, 15 parts of Rhizoma Pinelliae Preparata, 12 parts of Pericarpium Citri Reticulataes, 10 parts of Ramulus Cinnamomi, 30 parts of Rhizoma Alismatis, 15 parts of Rhizoma Atractylodis, 12 parts of Fructus Aurantiis, 12 parts of Radix Ophiopogonis.
3. the Chinese medicine composition of treatment coronary heart disease according to claim 1 and 2 is characterized in that, described medicament is an oral formulations.
CN2011100261281A 2011-01-24 2011-01-24 Chinese medicinal composition for treating coronary heart disease Expired - Fee Related CN102078510B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100261281A CN102078510B (en) 2011-01-24 2011-01-24 Chinese medicinal composition for treating coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100261281A CN102078510B (en) 2011-01-24 2011-01-24 Chinese medicinal composition for treating coronary heart disease

Publications (2)

Publication Number Publication Date
CN102078510A CN102078510A (en) 2011-06-01
CN102078510B true CN102078510B (en) 2011-11-16

Family

ID=44084834

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100261281A Expired - Fee Related CN102078510B (en) 2011-01-24 2011-01-24 Chinese medicinal composition for treating coronary heart disease

Country Status (1)

Country Link
CN (1) CN102078510B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102727691A (en) * 2012-06-08 2012-10-17 何春生 Collateral-dredging heart-comforting pellets
CN102698234A (en) * 2012-06-09 2012-10-03 李承平 Tablet for activating yang, removing stasis, promoting circulation of qi, and widening chest
CN102670970A (en) * 2012-06-28 2012-09-19 孙凤英 Traditional Chinese medicine composition for treating coronary heart disease
CN102961703B (en) * 2012-11-14 2014-02-26 凤台县中医院 Traditional Chinese medicine for treating chest discomfort and cardiodynia
CN103127470A (en) * 2013-03-16 2013-06-05 刘建飞 Traditional Chinese medicine composition for treating coronary diseases
CN103316226B (en) * 2013-06-24 2014-12-10 朱桂玲 Traditional Chinese medicine composition for treating coronary heart disease
CN105687962A (en) * 2014-03-07 2016-06-22 陈西成 Electuary capable of treating atherosclerosis of coronary artery and preparation method thereof
CN104208398A (en) * 2014-08-25 2014-12-17 赵阳阳 Medicine for treating coronary heat disease, angina and arrhythmia and preparation method thereof
CN104922505A (en) * 2015-05-31 2015-09-23 济南邦文医药科技有限公司 Traditional Chinese medicine for treating coronary heart disease stable angina pectoris complicated with hypertension and hyperlipidemia
CN104887921A (en) * 2015-06-09 2015-09-09 沈萍 Traditional Chinese medicine composition for treating chest stuffiness and pain
CN105030886A (en) * 2015-09-03 2015-11-11 佛山市朗达信息科技有限公司 Composite capable of treating coronary heart disease.
CN105079768A (en) * 2015-09-25 2015-11-25 冷国玉 Traditional Chinese medicine composition for treating coronary heart disease caused by syndrome of phlegm obstruction
CN105853847A (en) * 2016-05-25 2016-08-17 上海市中医医院 Traditional Chinese medicine composition for treating triple-vessel disease of coronary heart disease and application thereof
CN105935429A (en) * 2016-07-14 2016-09-14 魏作平 Traditional Chinese medicine composition for treating coronary heart disease and hypertension
CN106421303A (en) * 2016-10-31 2017-02-22 上海中医药大学附属岳阳中西医结合医院 Chinese medicine composite for control of phlegm turbidity closed type coronary disease and apply thereof
CN109464632A (en) * 2018-12-27 2019-03-15 同溢堂药业有限公司 A kind of drug and preparation method thereof for treating coronary heart disease
CN112755149A (en) * 2020-12-30 2021-05-07 西安交通大学医学院第一附属医院 Traditional Chinese medicine composition for treating coronary heart disease and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1334121A (en) * 2001-08-31 2002-02-06 石家庄以岭药业有限公司 Medicinal composition for restoring cardiac collaterals and its application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1334121A (en) * 2001-08-31 2002-02-06 石家庄以岭药业有限公司 Medicinal composition for restoring cardiac collaterals and its application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
潘志伟,顾宁.中药复方治疗冠心病心绞痛研究现状.《实用中医药杂志》.2010,第26卷(第3期),204-205. *

Also Published As

Publication number Publication date
CN102078510A (en) 2011-06-01

Similar Documents

Publication Publication Date Title
CN102078510B (en) Chinese medicinal composition for treating coronary heart disease
CN101507765B (en) Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof
CN105561214A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN105056124A (en) Medicine for treating hypertension and diabetes
CN104740289A (en) Traditional Chinese medicine for treating coronary heart disease
CN103041336B (en) Traditional Chinese medicine composition for treating coronary heart disease
CN102283956B (en) Orally administered drug for treating chronic hepatitis
CN102631538B (en) Traditional Chinese medicine for treating heart disease
CN104013919A (en) Traditional Chinese medicine for treating angina pectoris
CN101524470A (en) Traditional Chinese medicine preparation for curing angiocardiopathy stent restenosis and preparation method thereof
CN102048939B (en) Medicament for treating sinus bradycardia
CN105796789A (en) Traditional Chinese medicine preparation for treating coronary heart disease
CN103142897B (en) Medicine used after esophageal achalasia operation
CN103212041B (en) Chinese medicinal composition treating coronary heart disease
CN102631607B (en) Medicament for treating cardiovascular diseases and preparation method thereof
CN105126034A (en) Pharmaceutical preparation for treating coronary heart disease
CN104117018A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN104189714A (en) Traditional Chinese medicine capsule for treating coronary heart disease
CN103495108A (en) Medicine for treating chronic hypotension and preparation method for medicine
CN103142898B (en) Preparation method of medicine used after esophageal achalasia operation
CN102743578B (en) Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction
CN102397391A (en) Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof
CN102335203A (en) Miniature decoction
CN106177422A (en) A kind of Chinese medicine formula of warming YANG to expel cold
CN105770520A (en) Medicine preparation used for treating coronary heart disease and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111116

Termination date: 20130124